Tag: Skin Disorders: Misc.
Antibiotic Choices for Skin, Soft Tissue Infections Vary by Race
Compared with White inpatients, Black inpatients less likely to receive cefazolin, more likely to receive clindamycin for SSTIs
COVID-19 Severity Does Not Differ for Patients With Skin Conditions
Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria
Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas
Randomized clinical trial shows oral nadolol noninferior to oral propranolol for treatment of infantile hemangiomas
Adalimumab Efficacious Adjunct to Surgery for Hidradenitis Suppurativa
Risk for postoperative wound infection, complications, hemorrhage no greater with adalimumab versus placebo in hidradenitis suppurativa
Questionnaire Responses About Dermatology History Inconsistent
History of psoriasis consistently reported, whereas history of atopic dermatitis is not
COVID-19 Weakly Correlated With Chilblains Incidence
However, only 3.7 percent of the 456 patients with chilblains were positive for SARS-CoV-2
Risk Factors for PHACE Syndrome ID’d in Infantile Hemangiomas
Surface area of 25 cm2 or more, involvement of three or more locations linked to increased risk
Rituximab, Mycophenolate Mofetil Compared for Pemphigus Vulgaris
More patients receiving rituximab versus mycophenolate mofetil had sustained complete remission at week 52, fewer had disease flares
Delayed Hypersensitivity Reaction to Moderna COVID-19 Vaccine ID’d
Reaction occurred at or near injection site; reactions were pruritic, painful, and edematous pink plaques
Topical Corticosteroid Use in Pregnancy Not Tied to SGA, LBW
Risks for small for gestational age or low birth weight not increased with exposure to potent or very potent topical corticosteroids
